Correlation Between Morgan Stanley and MyMD Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and MyMD Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and MyMD Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Morgan Stanley Direct and MyMD Pharmaceuticals, you can compare the effects of market volatilities on Morgan Stanley and MyMD Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of MyMD Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and MyMD Pharmaceuticals.

Diversification Opportunities for Morgan Stanley and MyMD Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Morgan and MyMD is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and MyMD Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MyMD Pharmaceuticals and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with MyMD Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MyMD Pharmaceuticals has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and MyMD Pharmaceuticals go up and down completely randomly.

Pair Corralation between Morgan Stanley and MyMD Pharmaceuticals

If you would invest  1,929  in Morgan Stanley Direct on September 26, 2024 and sell it today you would earn a total of  172.00  from holding Morgan Stanley Direct or generate 8.92% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.59%
ValuesDaily Returns

Morgan Stanley Direct  vs.  MyMD Pharmaceuticals

 Performance 
       Timeline  
Morgan Stanley Direct 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.
MyMD Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MyMD Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, MyMD Pharmaceuticals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Morgan Stanley and MyMD Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Morgan Stanley and MyMD Pharmaceuticals

The main advantage of trading using opposite Morgan Stanley and MyMD Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, MyMD Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MyMD Pharmaceuticals will offset losses from the drop in MyMD Pharmaceuticals' long position.
The idea behind Morgan Stanley Direct and MyMD Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.